Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

New pharmacogenetic test for detecting an HLA-A*31: 01 allele using the InvaderPlus assay.

Pharmacogenetics and genomics - 1 Jun 2012

Aoki Masayuki, Hosono Naoya, Takata Sadaaki, Nakamura Yusuke, Kamatani Naoyuki, Kubo Michiaki

Abstract excerpt

BACKGROUND & AIMS: Carbamazepine (CBZ) is widely used for the treatment of epilepsy and other neurological disorders. However, 3-5% of CBZ-treated individuals suffer from cutaneous adverse drug reactions (cADRs). Recently, in a genome-wide association study, HLA-A*31:01 has been reported to be a...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Alleles
Share to Asian People
Share to DNA Primers

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Ethnicity

Share to HLA-A Antigens

Share to Pharmacogenetics

Share to Reagent Kits, Diagnostic

Source

Identifiers

PMID: 22453764
DOI: 10.1097/FPC.0b013e3283527c40

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026. Prepared record publication-22453764-2026-09-04.2. Manifest publication-graph-cohort-2026-09-04.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

New pharmacogenetic test for detecting an HLA-A*31: 01 allele using the InvaderPlus assay.PMID 22453764Read ↗

The HLA-A*31:01 allele: influence on carbamazepine treatmentSemantic proximity Read ↗

Association of HLA-A*31:01 Screening With the Incidence of Carbamazepine-Induced Cutaneous Adverse Reactions in a Japanese PopulationSemantic proximity Read ↗

Carbamazepine-induced cutaneous reactions: a simple assay to identify patients carrying the HLA-A*31:01 allele.Semantic proximity Read ↗

Single-tube multiplex real-time PCR assay for rapid and reliable detection of HLA-A*31:01 allele.Semantic proximity Read ↗

Development of a simple genotyping method for the HLA-A*31:01-tagging SNP in Japanese.Semantic proximity Read ↗

The risk of cutaneous adverse reactions among patients with the <i>HLA-A* 31:01</i> allele who are given carbamazepine, oxcarbazepine or eslicarbazepine: a perspective reviewSemantic proximity Read ↗

Genome-wide association study identifies HLA-A*3101 allele as a genetic risk factor for carbamazepine-induced cutaneous adverse drug reactions in Japanese population.Semantic proximity Read ↗

Development of a simple method for detection of the HLA-A*31:01 allele.Semantic proximity Read ↗

Simple and rapid detection of HLA-A*31:01 for prediction of carbamazepine-induced hypersensitivity using loop-mediated isothermal amplification method.Semantic proximity Read ↗

Clinical Pharmacogenetics Implementation Consortium Guideline for HLA Genotype and Use of Carbamazepine and Oxcarbazepine: 2017 UpdateSemantic proximity Read ↗

Development of new HLA-B*3505 genotyping method using Invader assay.Semantic proximity Read ↗

A novel multiplex polymerase chain reaction assay for detection of both HLA-A*31:01/HLA-B*15:02 alleles, which confer susceptibility to carbamazepine-induced severe cutaneous adverse reactions.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.